PT  - JOURNAL ARTICLE
AU  - Anne E.  Tebo
AU  - Robert L.  Schmidt
AU  - Tracy M.  Frech
TI  - Dr. Tebo, &lt;em&gt;et al&lt;/em&gt;, reply
AID  - 10.3899/jrheum.190594
DP  - 2019 Aug 01
TA  - The Journal of Rheumatology
PG  - jrheum.190594
4099  - http://www.jrheum.org/content/early/2019/07/23/jrheum.190594.short
4100  - http://www.jrheum.org/content/early/2019/07/23/jrheum.190594.full
AB  - We read with great interest the response by Drs. Jearn and Kim1 to our letter “Presence of Anti-topoisomerase I Antibody Alone May Not Be Sufficient for the Diagnosis of Systemic Sclerosis”2. We agree with Drs. Jearn and Kim that the antinuclear antibody (ANA)-negative accompanied by antitopoisomerase I antibody (anti-topo I) positivity is not sufficient to diagnose systemic sclerosis (SSc).